Keyphrases
Topotecan
100%
Distant Metastasis
100%
Complete Response
100%
Maintenance Therapy
100%
Invasive Cervical Cancer
100%
Erlotinib
100%
Recurrent Disease
33%
Cisplatin
33%
Epidermal Growth Factor Receptor Inhibitors
33%
Chemoradiation
33%
Radiotherapy
16%
Radiation Therapy
16%
Poor Prognosis
16%
Treatment Response
16%
Older Women
16%
Long Interval
16%
New Therapies
16%
Biological Relevance
16%
Toxicity Profile
16%
Sustained Response
16%
Stage IB2
16%
Squamous Cell Carcinoma of the Cervix
16%
Para-aortic Lymph Node
16%
Recurrent Metastatic
16%
Supraclavicular Lymph Node
16%
Radiation Field
16%
3-cycle
16%
Common Iliac
16%
Metastatic Cervical Cancer
16%
Medicine and Dentistry
Cervical Cancer
100%
Topotecan
100%
Distant Metastasis
100%
Maintenance Therapy
100%
Erlotinib
100%
Recurrent Disease
50%
Diseases
33%
Radiation Therapy
33%
Cisplatin
33%
Chemoradiotherapy
33%
Epidermal Growth Factor Receptor Kinase Inhibitor
33%
Squamous Cell Carcinoma
16%
Treatment Response
16%
Side Effect
16%
Paraaortic Lymph Node
16%
Cervix
16%
Supraclavicular Lymph Node
16%
Pharmacology, Toxicology and Pharmaceutical Science
Distant Metastasis
100%
Topotecan
100%
Erlotinib
100%
Uterine Cervix Cancer
100%
Recurrent Disease
50%
Diseases
33%
Cisplatin
33%
Chemoradiation Therapy
33%
Epidermal Growth Factor Receptor Kinase Inhibitor
33%
Squamous Cell Carcinoma
16%
Side Effect
16%